Overall rank by patents
#38,745
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B65B (MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING).
The verdict
Avercon holds 6 US patents across 3 technology areas, rank #38,745 of 50,000 tracked assignees.
Avercon BVBA has been granted 6 US utility patents between 2022 and 2025, placing Avercon BVBA at rank #38,745 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.8 claims per patent with primary concentration in B65B (MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING). As a Foreign Corporation, Avercon BVBA is one of the more focused assignees in the PatentsView dataset. By volume, Avercon sits between Auxitrol S.a. (6 patents, rank #38,741) and AVS, Ingenieur J.c. Römer Gmbh (6 patents, rank #38,749) - the closest US assignees by grant volume. The composite Innovation Score of 46.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 6 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Avercon BVBA's 21.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Avercon BVBA against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AUXITROL S.A.
6 patents
AVANAN Inc.
6 patents
AVENTIS PHARMA S.A.
6 patents
AVENTOM Ltd.
6 patents
AVIDASPORTS, LLC.
6 patents
AVITA INTERNATIONAL LTD.
6 patents
AVM Biotechnology, LLC
6 patents
AVS, Ingenieur J.C. Römer GmbH
6 patents
AVERCON BVBA
6 patents
What this shows Avercon holds 6 patents at rank #38,745, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #38,745 in granted patent volume.
Other assignees with the most granted patents in Avercon's primary technology class.
Avercon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 2 | 33.3% |
| 2023 | 2 | 33.3% |
| 2024 | 1 | 16.7% |
| 2025 | 1 | 16.7% |
Top 3 of 3 technology areas
Overall rank by patents
#38,745
Across all tracked assignees
46.0 out of 100
How to use this portfolio
Avercon's 6 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.